These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 16376417

  • 21. Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Aravantinos G, Fountzilas G, Bamias A, Grimani I, Rizos S, Kalofonos HP, Skarlos DV, Economopoulos T, Kosmidis PA, Stathopoulos GP, Briasoulis E, Pectasides D, Samantas E, Timotheadou E, Papadimitriou C, Papanikolaou A, Onyenadum A, Papakostas P, Bafaloukos D, Dimopoulos MA, Hellenic Cooperative Oncology Group study.
    Eur J Cancer; 2008 Oct; 44(15):2169-77. PubMed ID: 18691879
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
    Liu J, Tu D, Dancey J, Reyno L, Pritchard KI, Pater J, Seymour LK.
    Breast Cancer Res Treat; 2006 Dec; 100(3):263-71. PubMed ID: 16823511
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S, Gynecologic Oncology Group.
    J Clin Oncol; 2007 Jul 01; 25(19):2804-10. PubMed ID: 17502627
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Quality of life in ovarian cancer patients receiving chemotherapy.
    Lakusta CM, Atkinson MJ, Robinson JW, Nation J, Taenzer PA, Campo MG.
    Gynecol Oncol; 2001 Jun 15; 81(3):490-5. PubMed ID: 11371144
    [Abstract] [Full Text] [Related]

  • 30. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS.
    Clin Oncol (R Coll Radiol); 2009 Aug 15; 21(6):488-93. PubMed ID: 19386478
    [Abstract] [Full Text] [Related]

  • 31. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
    Peppercorn J, Herndon J, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E.
    Cancer; 2005 Oct 15; 104(8):1580-9. PubMed ID: 16118805
    [Abstract] [Full Text] [Related]

  • 32. Determining the relationship between toxicity and quality of life in an ovarian cancer chemotherapy clinical trial.
    Butler L, Bacon M, Carey M, Zee B, Tu D, Bezjak A.
    J Clin Oncol; 2004 Jun 15; 22(12):2461-8. PubMed ID: 15197209
    [Abstract] [Full Text] [Related]

  • 33. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH, van Groeningen CJ, Wormhoudt LW, Giaccone G.
    Oncologist; 2006 Feb 15; 11(2):197-205. PubMed ID: 16476840
    [Abstract] [Full Text] [Related]

  • 34. Treatment for advanced cervical cancer: impact on quality of life.
    Davidson S.
    Crit Rev Oncol Hematol; 2011 Jul 15; 79(1):24-30. PubMed ID: 20810289
    [Abstract] [Full Text] [Related]

  • 35. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
    McMeekin DS, Filiaci VL, Thigpen JT, Gallion HH, Fleming GF, Rodgers WH, Gynecologic Oncology Group study.
    Gynecol Oncol; 2007 Jul 15; 106(1):16-22. PubMed ID: 17574073
    [Abstract] [Full Text] [Related]

  • 36. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
    Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Method M, Michael H, Tewari KS.
    Lancet Oncol; 2015 Mar 15; 16(3):301-11. PubMed ID: 25638326
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy for recurrent cervical cancer.
    Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E.
    Cancer Treat Rev; 2008 Nov 15; 34(7):603-13. PubMed ID: 18657909
    [Abstract] [Full Text] [Related]

  • 38. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
    Dimitroulis J, Rapti A, Stathopoulos GP, Rigatos S, Stathopoulos J, Koutantos J, Athanasiadis A, Tsikritsaki K, Karaindros D, Katis K, Antoniou D, Toumbis M, Giamboudakis P.
    Oncol Rep; 2008 Oct 15; 20(4):879-84. PubMed ID: 18813830
    [Abstract] [Full Text] [Related]

  • 39. Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial.
    Kurtz JE, Hardy-Bessard AC, Deslandres M, Lavau-Denes S, Largillier R, Roemer-Becuwe C, Weber B, Guillemet C, Paraiso D, Pujade-Lauraine E.
    Gynecol Oncol; 2009 Apr 15; 113(1):16-20. PubMed ID: 19232434
    [Abstract] [Full Text] [Related]

  • 40. Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1378-84. PubMed ID: 18501528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.